population. Uncertainties also exist about the safety and efficacy of anti-osteoporotic drugs such asbisphosphonatesanddenosumabin patients with advanced CKD.22,23,24Thus the Summit did not insist strongly on performing and reimbursing a DEXA scan for patients with CKD G3a–G5D. However, the ...